Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s12885-024-12006-1.

Title:
Inhibition of growth of hepatocellular carcinoma by co-delivery of anti-PD-1 antibody and sorafenib using biomimetic nano-platelets | BMC Cancer
Description:
Background Traditional nanodrug delivery systems have some limitations, such as eliciting immune responses and inaccuracy in targeting tumor microenvironments. Materials and methods Targeted drugs (Sorafenib, Sora) nanometers (hollow mesoporous silicon, HMSN) were designed, and then coated with platelet membranes to form aPD-1-PLTM-HMSNs@Sora to enhance the precision of drug delivery systems to the tumor microenvironment, so that more effective immunotherapy was achieved. Results These biomimetic nanoparticles were validated to have the same abilities as platelet membranes (PLTM), including evading the immune system. The successful coating of HMSNs@Sora with PLTM was corroborated by transmission electron microscopy (TEM), western blot and confocal laser microscopy. The affinity of aPD-1-PLTM-HMSNs@Sora to tumor cells was stronger than that of HMSNs@Sora. After drug-loaded particles were intravenously injected into hepatocellular carcinoma model mice, they were demonstrated to not only directly activate toxic T cells, but also increase the triggering release of Sora. The combination of targeted therapy and immunotherapy was found to be of gratifying antineoplastic function on inhibiting primary tumor growth. Conclusions The aPD-1-PLTM-HMSNs@Sora nanocarriers that co-delivery of aPD-1 and Sorafenib integrates unique biomimetic properties and excellent targeting performance, and provides a neoteric idea for drug delivery of personalized therapy for primary hepatocellular carcinoma (HCC).
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

tumor, cells, article, sora, apdpltmhmsnssora, google, scholar, apd, cancer, fig, hmsns, cas, nanoparticles, immune, mice, platelet, cell, platelets, therapy, pltmhmsns, pltm, effect, group, antitumor, drug, growth, carcinoma, targeted, liver, treatment, membrane, biomimetic, surface, vivo, targeting, blood, data, hepatocellular, delivery, drugs, particles, hepg, microenvironment, results, size, sorafenib, chen, immunotherapy, hmsnssora, expression,

Topics {✒️}

anti-pd-1/pd-l1 therapy pltm-hmsns reached 500 µg/ml anti-pd-1 / pd-l1 molecular weight rejection = 20 kda repeated freeze-thaw cycles transferrin-functionalized nanoparticles lose tukey post-hoc test post-surgery tumour recurrence platelet-facilitated photothermal therapy article download pdf tumor anti-angiogenic therapies anticancer platelet-mimicking nanovehicles platelet membrane-coated nanoparticles amplificated low-dose radiotherapy cancer-cell-biomimetic nanoparticles hollow mesoporous silicon h22 tumor-bearing balb/ enhanced anti-tumor efficacy delivering anti-cancer drugs prepare fitc-labeled hmsns platelet-specific expression protein delivery anti-cancer drugs enhanced anti-tumor effect ferroptosis-enhanced cancer immunotherapy drug-loaded pltm-hmsns drug delivery systems h22 tumor-bearing mice anti-pdl1-conjugated platelets obtained ssio2-nh2 nanoparticles anti-pd-1 antibody silica-etching chemistry 1 mg/ml trauts reagent group supplied apd-1 + sora nanodrug delivery system privacy choices/manage cookies tumor immune microenvironment platelet biomimetic nanomaterials effectively transfer apd-1 platelet membrane protein related subjects hep-g2 cells incubated platelet membrane proteins remodeling tumor microenvironment platelet biomimetic nanoparticles platelet-biomimetic nanoparticles tumor killing effect vascular injury response h22 cell line platelet membrane cloaking full access

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Inhibition of growth of hepatocellular carcinoma by co-delivery of anti-PD-1 antibody and sorafenib using biomimetic nano-platelets
         description:Traditional nanodrug delivery systems have some limitations, such as eliciting immune responses and inaccuracy in targeting tumor microenvironments. Targeted drugs (Sorafenib, Sora) nanometers (hollow mesoporous silicon, HMSN) were designed, and then coated with platelet membranes to form aPD-1-PLTM-HMSNs@Sora to enhance the precision of drug delivery systems to the tumor microenvironment, so that more effective immunotherapy was achieved. These biomimetic nanoparticles were validated to have the same abilities as platelet membranes (PLTM), including evading the immune system. The successful coating of HMSNs@Sora with PLTM was corroborated by transmission electron microscopy (TEM), western blot and confocal laser microscopy. The affinity of aPD-1-PLTM-HMSNs@Sora to tumor cells was stronger than that of HMSNs@Sora. After drug-loaded particles were intravenously injected into hepatocellular carcinoma model mice, they were demonstrated to not only directly activate toxic T cells, but also increase the triggering release of Sora. The combination of targeted therapy and immunotherapy was found to be of gratifying antineoplastic function on inhibiting primary tumor growth. The aPD-1-PLTM-HMSNs@Sora nanocarriers that co-delivery of aPD-1 and Sorafenib integrates unique biomimetic properties and excellent targeting performance, and provides a neoteric idea for drug delivery of personalized therapy for primary hepatocellular carcinoma (HCC).
         datePublished:2024-02-26T00:00:00Z
         dateModified:2024-02-26T00:00:00Z
         pageStart:1
         pageEnd:12
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12885-024-12006-1
         keywords:
            Platelet membrane
            Immunotherapy
            Sorafenib
            Tumor microenvironment
            Nanoparticles
            Cancer Research
            Oncology
            Surgical Oncology
            Health Promotion and Disease Prevention
            Biomedicine
            general
            Medicine/Public Health
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-024-12006-1/MediaObjects/12885_2024_12006_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-024-12006-1/MediaObjects/12885_2024_12006_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-024-12006-1/MediaObjects/12885_2024_12006_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-024-12006-1/MediaObjects/12885_2024_12006_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-024-12006-1/MediaObjects/12885_2024_12006_Fig5_HTML.png
         isPartOf:
            name:BMC Cancer
            issn:
               1471-2407
            volumeNumber:24
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Xuanbo Da
               affiliation:
                     name:Tongji University
                     address:
                        name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Bangping Cao
               affiliation:
                     name:Tongji University
                     address:
                        name:School and Hospital of Stomatology, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Tongji University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jiantao Mo
               affiliation:
                     name:First Affiliated Hospital of Xi’an Jiaotong University
                     address:
                        name:Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yukai Xiang
               affiliation:
                     name:Tongji University
                     address:
                        name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hai Hu
               affiliation:
                     name:Tongji University
                     address:
                        name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chen Qiu
               affiliation:
                     name:Tongji University
                     address:
                        name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Cheng Zhang
               affiliation:
                     name:Tongji University
                     address:
                        name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Beining Lv
               affiliation:
                     name:Tongji University
                     address:
                        name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Honglei Zhang
               affiliation:
                     name:Tongji University
                     address:
                        name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chuanqi He
               affiliation:
                     name:Tongji University
                     address:
                        name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yulong Yang
               affiliation:
                     name:Tongji University
                     address:
                        name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Inhibition of growth of hepatocellular carcinoma by co-delivery of anti-PD-1 antibody and sorafenib using biomimetic nano-platelets
      description:Traditional nanodrug delivery systems have some limitations, such as eliciting immune responses and inaccuracy in targeting tumor microenvironments. Targeted drugs (Sorafenib, Sora) nanometers (hollow mesoporous silicon, HMSN) were designed, and then coated with platelet membranes to form aPD-1-PLTM-HMSNs@Sora to enhance the precision of drug delivery systems to the tumor microenvironment, so that more effective immunotherapy was achieved. These biomimetic nanoparticles were validated to have the same abilities as platelet membranes (PLTM), including evading the immune system. The successful coating of HMSNs@Sora with PLTM was corroborated by transmission electron microscopy (TEM), western blot and confocal laser microscopy. The affinity of aPD-1-PLTM-HMSNs@Sora to tumor cells was stronger than that of HMSNs@Sora. After drug-loaded particles were intravenously injected into hepatocellular carcinoma model mice, they were demonstrated to not only directly activate toxic T cells, but also increase the triggering release of Sora. The combination of targeted therapy and immunotherapy was found to be of gratifying antineoplastic function on inhibiting primary tumor growth. The aPD-1-PLTM-HMSNs@Sora nanocarriers that co-delivery of aPD-1 and Sorafenib integrates unique biomimetic properties and excellent targeting performance, and provides a neoteric idea for drug delivery of personalized therapy for primary hepatocellular carcinoma (HCC).
      datePublished:2024-02-26T00:00:00Z
      dateModified:2024-02-26T00:00:00Z
      pageStart:1
      pageEnd:12
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12885-024-12006-1
      keywords:
         Platelet membrane
         Immunotherapy
         Sorafenib
         Tumor microenvironment
         Nanoparticles
         Cancer Research
         Oncology
         Surgical Oncology
         Health Promotion and Disease Prevention
         Biomedicine
         general
         Medicine/Public Health
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-024-12006-1/MediaObjects/12885_2024_12006_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-024-12006-1/MediaObjects/12885_2024_12006_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-024-12006-1/MediaObjects/12885_2024_12006_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-024-12006-1/MediaObjects/12885_2024_12006_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12885-024-12006-1/MediaObjects/12885_2024_12006_Fig5_HTML.png
      isPartOf:
         name:BMC Cancer
         issn:
            1471-2407
         volumeNumber:24
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Xuanbo Da
            affiliation:
                  name:Tongji University
                  address:
                     name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Bangping Cao
            affiliation:
                  name:Tongji University
                  address:
                     name:School and Hospital of Stomatology, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Tongji University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jiantao Mo
            affiliation:
                  name:First Affiliated Hospital of Xi’an Jiaotong University
                  address:
                     name:Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yukai Xiang
            affiliation:
                  name:Tongji University
                  address:
                     name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hai Hu
            affiliation:
                  name:Tongji University
                  address:
                     name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chen Qiu
            affiliation:
                  name:Tongji University
                  address:
                     name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Cheng Zhang
            affiliation:
                  name:Tongji University
                  address:
                     name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Beining Lv
            affiliation:
                  name:Tongji University
                  address:
                     name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Honglei Zhang
            affiliation:
                  name:Tongji University
                  address:
                     name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chuanqi He
            affiliation:
                  name:Tongji University
                  address:
                     name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yulong Yang
            affiliation:
                  name:Tongji University
                  address:
                     name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:BMC Cancer
      issn:
         1471-2407
      volumeNumber:24
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Tongji University
      address:
         name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
         type:PostalAddress
      name:Tongji University
      address:
         name:School and Hospital of Stomatology, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Tongji University, Shanghai, China
         type:PostalAddress
      name:First Affiliated Hospital of Xi’an Jiaotong University
      address:
         name:Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
         type:PostalAddress
      name:Tongji University
      address:
         name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
         type:PostalAddress
      name:Tongji University
      address:
         name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
         type:PostalAddress
      name:Tongji University
      address:
         name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
         type:PostalAddress
      name:Tongji University
      address:
         name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
         type:PostalAddress
      name:Tongji University
      address:
         name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
         type:PostalAddress
      name:Tongji University
      address:
         name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
         type:PostalAddress
      name:Tongji University
      address:
         name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
         type:PostalAddress
      name:Tongji University
      address:
         name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Xuanbo Da
      affiliation:
            name:Tongji University
            address:
               name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Bangping Cao
      affiliation:
            name:Tongji University
            address:
               name:School and Hospital of Stomatology, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Tongji University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Jiantao Mo
      affiliation:
            name:First Affiliated Hospital of Xi’an Jiaotong University
            address:
               name:Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
               type:PostalAddress
            type:Organization
      name:Yukai Xiang
      affiliation:
            name:Tongji University
            address:
               name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Hai Hu
      affiliation:
            name:Tongji University
            address:
               name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Chen Qiu
      affiliation:
            name:Tongji University
            address:
               name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Cheng Zhang
      affiliation:
            name:Tongji University
            address:
               name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Beining Lv
      affiliation:
            name:Tongji University
            address:
               name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Honglei Zhang
      affiliation:
            name:Tongji University
            address:
               name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Chuanqi He
      affiliation:
            name:Tongji University
            address:
               name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Yulong Yang
      affiliation:
            name:Tongji University
            address:
               name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
      name:School and Hospital of Stomatology, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Tongji University, Shanghai, China
      name:Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
      name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
      name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
      name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
      name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
      name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
      name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
      name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China
      name:Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai, China

External Links {🔗}(181)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Particles.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.93s.